Haploidentical Transplantation for Advanced Hematologic Malignancies Using Melphalan-Based Conditioning – Mature Results from a Single Center  Sai Ravi Pingali, MD, Denai Milton, Antonio di Stasi, MD, Rushang D. Patel, MD, PhD, Partow Kebriaei, MD, Uday R. Popat, MD, Amin M. Alousi, MD, Paolo Anderlini, MD, Muzaffar H. Qazilbash, MD, Chitra Hosing, MD, Katy Rezvani, MD, Qaiser Bashir, MD, Betul Oran, MD, Elizabeth J. Shpall, MD, Issa F. Khouri, MD, Richard E. Champlin, MD, Stefan O. Ciurea, MD  Biology of Blood and Marrow Transplantation  Volume 20, Issue 2, Pages S40-S41 (February 2014) DOI: 10.1016/j.bbmt.2013.12.033 Copyright © 2014 Terms and Conditions

Figure 1 A. PFS first transplants, all patients; B. PFS for myeloid patients in remission. Biology of Blood and Marrow Transplantation 2014 20, S40-S41DOI: (10.1016/j.bbmt.2013.12.033) Copyright © 2014 Terms and Conditions